Dehaier Medical Announces Visit to Expand Footprint in Israel
October 21 2013 - 7:30AM
Dehaier Medical Systems Ltd. (Nasdaq:DHRM)
("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and
homecare medical products, today announced that its management team
will visit Israel to meet with high-tech medical companies and
pursue further discussions with its long-term partner, WideMed
Ltd., to broaden cooperation opportunities. The trip is scheduled
from October 21, 2013 to October 25, 2013.
Dehaier provides all-in-one solutions for the diagnosis,
evaluation and treatment of obstructive sleep apnea ("OSA"). Based
on support from WideMed, Dehaier has developed a new watch-sized
device, which can be integrated into WideMed's Morpheus Ox
platform. By collecting and recording physiological data from
patients who wear the watch-sized device at home, the advanced
automatic sleep scoring software generates an accurate and reliable
sleep study diagnosis, including Apnea Hypopnea Index ("AHI"),
sleep/wake time, and Cheyne-Stokes breathing patterns. The new
system is a comprehensive platform that manages a cost-effective
sleep services operation, including patient electronic medical
records, cardiac and sleep diagnostics outcomes and complete
workflow management. The web-based automatic scoring and data
management facilitates operational efficiency and maximizes growth
potential by giving users valuable and timely clinical information
to improve patient treatment.
Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier
Medical, commented, "Dehaier is focusing on research and
development, SFDA registration and marketing activities of
Efficient Sleep Diagnosis System. We deeply believe that the System
has great market demand and development potential. By visiting
WideMed and discussing further opportunities with them, we hope to
reach a long-term agreement and deepen our cooperation. In
addition, we believe that other Israeli high-tech medical companies
will benefit from learning about Dehaier's innovative and
revolutionary medical products."
About Dehaier Medical Systems
Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy), Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents, nine software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular any implications regarding the potential cooperation
talk with WideMed. These statements are subject to uncertainties
and risks including, but not limited to, product and service demand
and acceptance, changes in technology, economic conditions, the
impact of competition and pricing, government regulation, future
developments in payment for and demand for medical equipment and
services, implementation of and performance under the joint venture
agreement by all parties, and other risks contained in reports
filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and
whether made by or on behalf of the company, are expressly
qualified by the cautionary statements and any other cautionary
statements which may accompany the forward-looking statements. In
addition, the company disclaims any obligation to update any
forward-looking statements to reflect events or circumstances after
the date hereof.
CONTACT: Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024